Back to search

Article

Chromatin signalling pathways and FANCE amplification affect ATR inhibitor sensitivity in metastatic breast cancer

2025-08-31

Abstract excerpt

<h4>ABSTRACT</h4> Metastatic breast cancer remains incurable, as many patients develop therapy resistance. Loss of ATM/p53 increases reliance on the ATR pathway, positioning ATR inhibitors (ATRi) as promising therapeutics. However, targeting a single pathway often leads to resistance due to tumour heterogeneity or alternative signalling mechanisms. Here, we combine chromatin-enrichment proteomics and phospho-prot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0a8e8c90-218b-5bd8-9643-f5efa47040be
DOI
10.1101/2025.08.26.672363
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Chromatin signalling pathways and FANCE amplification affect ATR inhibitor sensitivity in metastatic breast cancerDOI 10.1101/2025.08.26.672363
Select a neighboring publication to make it the new centre.